
Clearing Up Confusion in Endometriosis Care (Part 2)
Clarifying why treatment feels confusing—and what key guidelines actually recommend.

Understanding Endometriosis Treatment Confusion
Endometriosis affects millions of women worldwide and is characterized by pain, irregular menstruation, and infertility. This article is Part 2 in a series on this topic. It summarizes and comments on the findings from a 2021 review that provided a detailed analysis of international endometriosis treatment guidelines available as of September 2020.
Although discrepancies between guidelines are common in many diseases, endometriosis is notable for the degree of variation. A 2018 review revealed that only about 7% of recommendations were comparable across international guidelines, and up to 28% of the recommendations were not supported by good research evidence. These gaps help explain the wide variation in doctors’ recommendations in clinical practice.
The most recent publication examined key guidance from organizations including the American College of Obstetricians and Gynecologists (ACOG), the Society of Obstetricians and Gynaecologists of Canada (SOGC), the European Society of Human Reproduction and Embryology (ESHRE), the Australian National Endometriosis Clinical and Scientific Trials (ACCESS), the Royal College of Obstetricians and Gynaecologists (RCOG), the French National College of Gynecologists and Obstetricians (CNGOF), the American Association of Gynecologic Laparoscopists (AAGL), and the German Society for Gynecology and Obstetrics (DGGG).
Across these guidelines, treatment considerations span non-hormonal pain management, hormonal therapies, surgical approaches, complementary and alternative options, infertility-related decisions, and emerging research. Many recommendations hinge on disease severity, patient goals such as fertility, and the skill and experience of the treating surgeon, particularly for deep infiltrating disease. While some therapies are broadly endorsed, others are limited by inconclusive evidence, side-effect profiles, or access and training requirements. The sections below synthesize the detailed guidance and points of agreement and disagreement.
Detailed Summary of Treatment Recommendations
Non-Hormonal Medical Pain Management
Nonsteroidal anti-inflammatory drugs (NSAIDs): Considered by all guidelines to be first-line therapy for dysmenorrhea and acyclic pelvic pain, but not specific for endometriosis. A diagnosis and targeted therapy is more prudent since a large review showed no difference in effectiveness between NSAIDs and placebo.
Get Clear on Your Treatment Options
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your VisitHormonal Treatment Options
- Progestins and Combined Oral Contraceptives (COCs): Widely recommended for initial pain management, although specific formulations and dosages vary across guidelines. There is little mention of compounded micronized progesterone, which is hard to study but may deserve consideration. The Levonorgestrel Intrauterine System (LNG-IUS) is particularly noted for localized progestin delivery, reduced systemic side effects, and effective pain control.
- Megace (Megestrol Acetate): A potent progestin recommended by several guidelines, though its use varies as a first-line versus second-line option. An additional benefit is less bone loss than that seen with GnRH agonist therapy.
- GnRH Agonists: Uniformly recommended across guidelines for severe symptoms after first-line therapy. Potential side effects, which can be long-lasting, include decreased bone density and menopausal-like symptoms. Add-back low-dose estrogen therapy can reduce symptoms. Most guidelines, and the FDA, recommend durations of 6 months or less.
- Emerging Hormonal Therapies (GnRH Antagonists): Gaining attention for rapid onset of action and fewer side effects compared to agonists, though the evidence is not conclusive.
- Danazol and Gestrinone: Older treatments with androgenic effects and less common use today due to side effects. Gestrinone is not currently available in the United States.
- Selective Estrogen Receptor Modulators (SERMs) and Selective Progesterone Receptor Modulators (SPRMs): Emerging options being explored for targeted action and potential benefits.
- Aromatase Inhibitors: Considered in some cases, especially for pain unresponsive to other treatments. Most guidelines agree this is a possible second-line option, but the evidence is not conclusive. A possible niche for effective use may be in post-menopausal patients who have endometriosis.
Surgical Approaches: Navigating the Complexities
- Laparoscopic Surgery: Endorsed for efficacy and reduced recovery time compared to laparotomy. The extent of surgery (complete versus partial removal of lesions) varies among guidelines, and studies are likely hampered by differing surgeon skill sets.
- Robotic Surgery: Highlighted by AAGL and others for benefits in complex cases, though cost and accessibility limit widespread use. Specialized training is required.
- Ablation vs. Excision: The choice remains contentious. Ablation is simpler, requires less technical skill, and applies to superficial lesions, but it may not be as effective long-term as excision, which more comprehensively removes visible disease. Surgeon skill is critical, and high variability may affect the ability to prove or disprove the effectiveness and safety of each method.
- Endometrioma: Cystectomy or excision of endometriomas is superior to drainage in terms of lower recurrence. Excision provides the opportunity for pathologic confirmation, which can be important when the presence of a tumor is unclear. When fertility is a major concern, the more atraumatic the surgical approach, the less the ovarian reserve is affected; surgeon expertise is critical.
- Deep Infiltrating Endometriosis: Highly specialized excisional surgeries are recommended because ablation does not work for these lesions. There is an even stronger emphasis on the surgeon’s expertise and patient selection. Some strongly believe that the best outcomes for advanced cases with highly distorted anatomy may rest with robotic surgery in the hands of a master surgeon.
- Hysterectomy: Considered a “definitive” or last-resort surgery, but it may be helpful for complete excision of endometriosis at any point. It also allows removal of co-existing pain-producing adenomyosis embedded in the uterine wall.
- LUNA (laparoscopic uterine nerve ablation) and PSN (presacral neurectomy): Multiple reviews suggest no benefit to LUNA but a possible benefit for PSN in selected cases. PSN is technically very challenging and treatment should be individualized. Studies on LUNA include a mix of ablation and excision, resulting in a lack of precision and potential confounding by surgeon skill level; a definitive conclusion may be elusive until better study methodologies are employed.
Complementary and Alternative Therapies: Exploring Additional Avenues
- Acupuncture and Electrotherapy (TENS): Mentioned as adjunct therapies in some guidelines, with encouraging results but a need for more research. These are low-risk options.
- Nutritional Supplements: Some guidelines suggest dietary changes and supplements might play a role in symptom management, including microbiome management for optimal estrogen metabolism. Large randomized studies are unlikely due to impractical size requirements, but personalized molecular medicine is prompting exploration of alternative methodologies to determine which diet and lifestyle approaches may be most effective.
Infertility and Endometriosis: A Delicate Balance
Surgical vs. Non-Surgical Approaches: The decision to pursue surgery in infertility cases is complex and depends on individual factors such as age, severity of endometriosis, and prior treatments. Reducing inflammation appears to benefit intrauterine implantation and gestation.
Emerging Treatments and Research
Future Directions: Ongoing research into immunotherapies, new hormonal agents, and gene or molecular therapy offers promising avenues for more personalized strategies.
Final Thoughts
Endometriosis management is a highly dynamic field with evolving guidelines and currently discrepant recommendations due to incomplete or low-quality scientific evidence. Understanding current options is crucial for women to make informed decisions. Regular consultations with endometriosis experts, staying updated on new research, and considering a multidisciplinary, holistic approach can significantly improve quality of life.
References
Kalaitzopoulos, D. R. Samartzis, N. Kolovos, G. N. Mareti, E. Samartzis, E. P. Eberhard, M. Dinas, K. & Daniilidis, A. (2021). Treatment of endometriosis: a review with comparison of 8 guidelines. _BMC Womens Health_, _21_(1), 397. DOI: 10.1186/s12905-021-01545-5
Hirsch M, Begum MR, Paniz É, Barker C, Davis CJ, Duffy J. Diagnosis and management of endometriosis: a systematic review of international and national guidelines. BJOG. 2018;125(5):556–64. DOI: 10.1111/1471-0528.14838
Quick Answers
How do I make the most of a short endometriosis appointment?
Go in with a one-page snapshot of your story so the limited time is spent on decision-making, not backtracking. The most helpful snapshot includes: your top 2–3 symptoms, the pattern (cyclical vs daily, triggers, where pain starts and spreads), what you’ve already tried and what happened, and what your symptoms keep you from doing (work, school, intimacy, exercise). If you have a history of “normal” scans, bring that too—because imaging can miss endometriosis, and the pattern of symptoms and prior response to treatment still matters.
Bring the right records if you have them—especially operative reports, pathology, and imaging reports (and ideally the actual images). Then decide your goal for the visit: diagnostic clarity, a plan to evaluate look-alike or coexisting conditions, or a clear surgical discussion (whether surgery is likely to help, anticipated scope, and what recovery may involve). If you want to make the appointment count even more, reach out to our team ahead of time so we can review what you’ve already done and tell you exactly what information would be most useful for a focused, productive conversation.
Can endometriosis cause inflammation-related weight gain?
Yes—there can be a connection, but it’s usually not as simple as “inflammation makes you gain fat.” Endometriosis is an inflammatory condition, and that inflammation can drive fluid shifts, pelvic and abdominal swelling, bowel slowing/constipation, and the classic waxing-and-waning “endo belly,” all of which can look and feel like weight gain even when body fat hasn’t changed. Pain, fatigue, and stress can also reduce activity or change appetite patterns, which can indirectly affect body composition over time.
What’s also emerging in research is a possible link between endometriosis and certain metabolic risk patterns in some people (like central waist changes and lipid markers). That doesn’t prove endometriosis directly causes metabolic changes—or that metabolic changes cause endometriosis—but it does support why some patients feel their body is harder to “regulate” while the disease is active. If weight changes, bloating, or a new shift in your waistline is part of your story, our team can help you sort out what’s most likely inflammation and GI distension versus longer-term metabolic or hormonal contributors, and build a plan that aligns with your symptoms and goals. If you’d like, you can reach out to schedule a consultation so we can evaluate the full picture and discuss treatment options, including excision and coordinated whole-person care.
What are alternatives to ibuprofen for endometriosis pain?
If ibuprofen isn’t working for you—or you can’t take it—there are still several evidence-based ways we can approach endometriosis pain, depending on what’s driving it. Some pain is more inflammatory and cramp-like, while other pain behaves more like nerve pain (burning, electric, radiating) or becomes amplified over time through central sensitization. That’s why the “best” alternative isn’t one universal medication, but a plan matched to your pain pattern and goals (including fertility).
On the medication side, alternatives may include other NSAIDs, acetaminophen, and—when symptoms fit—neuropathic pain modulators (commonly medications used for nerve pain) that help calm overactive pain signaling. Some patients also ask about low-dose naltrexone; it’s a promising option for certain centralized pain conditions, but it isn’t proven as an endometriosis-specific treatment, so we treat it as an adjunct with careful expectations. Non-medication options can be genuinely useful too, especially when layered together—things like home electrical stimulation (TENS) for flares, and pain-focused psychological strategies that reduce the pain–stress amplification loop.
Most importantly, alternatives to ibuprofen are about managing symptoms while we keep sight of the underlying disease: symptom control alone can feel like a band-aid if active lesions are still driving inflammation, scarring, and organ irritation. Our team can help you sort out what type(s) of pain you’re experiencing and build a multimodal plan that fits your body and your timeline—whether you’re pursuing definitive diagnosis, considering excision surgery, or trying to stabilize day-to-day function in the meantime. If you’d like, reach out to schedule a consultation so we can personalize options rather than relying on trial-and-error.
What if I can’t take NSAIDs for endometriosis pain?
When you can’t take NSAIDs, it often exposes an important truth about endometriosis care: anti‑inflammatories may blunt symptoms, but they don’t treat the disease itself. Without NSAIDs, some people notice that flares feel more intense or last longer—especially if pain has become “wired in” over time through nervous system sensitization (meaning the body learns to amplify pain signals). That doesn’t mean you’re out of options; it means we need a more structured plan than a single medication.
In our practice, we typically think in layers: addressing pain drivers (inflammatory, hormonal, nerve-related, and musculoskeletal) while also evaluating whether endometriosis or adenomyosis itself needs definitive treatment. Non‑medication tools can play a bigger role here—especially pelvic floor therapy for muscle guarding and pelvic nerve irritation, and nervous-system-focused strategies that reduce pain amplification over time. If symptoms are escalating or you’re relying on workarounds because NSAIDs aren’t safe for you, that’s often the point when it’s worth stepping back and building a comprehensive plan with our team, including discussion of excision surgery when indicated and coordinated support to improve day-to-day function.
Can endometriosis cause a pulling or tugging sensation?
Yes—endometriosis can cause a pulling, tugging, or “stuck” sensation in the pelvis or lower abdomen. This often comes from inflammation and fibrosis (scar-like tissue) that can tether organs to each other or to the pelvic sidewall, so movements like standing upright, stretching, twisting, bowel movements, or sex may feel like something is being pulled.
That pulling sensation can also show up alongside other endometriosis patterns—pain that worsens around your period or ovulation, deep pain with intercourse, bowel or bladder pain, or a feeling of pressure and heaviness. Because endometriosis can involve many structures (including bowel, bladder, ureters, and deeper pelvic tissues), the exact “tug” you feel can hint at where disease may be affecting anatomy and nerves.
If you’re noticing this symptom, we encourage you to track when it happens (cycle timing, specific movements, bowel/bladder activity) and what else comes with it—those details help us map likely sources and plan a targeted evaluation. When appropriate, minimally invasive excision surgery can both confirm the diagnosis (with biopsy) and remove tethering disease to relieve symptoms—reach out to schedule a consultation with our team to talk through your history and options.

